Table 2 Postural balance (scaled velocity moment [m2/s]). Baseline and percentages changes after 12 months of treatment with melatonin or placebo (median with 25–75 % interquartile range
Baseline (m2/s) | P-value | Changes after 12 months (%) | P-value* | |
|---|---|---|---|---|
Normal standing, eyes open | 0.04 | 0.11 | ||
Placebo | 4.1 (2.9;6.4) | −10.98 (−30.39;19.00) | ||
Melatonin | 3.3 (2.7;4.1) | 6.30 (−22.83;43.43) | ||
Normal standing, eyes closed | 0.31 | 0.29 | ||
Placebo | 5.7 (3.6;8.5) | −7.79 (−39.72;33.31) | ||
Melatonin | 4.7 (3.4; 6.7) | 4.06 (−24.17;50.00) | ||
Semi tandem | 0.58 | 0.67 | ||
Placebo | 20.4 (15.6;33.1) | −4.97 (−33.98;29.42) | ||
Melatonin | 20.5 (16.4; 28.7) | −15.60 (−26.79;23.33) | ||
Tandem | 0.48 | 0.55 | ||
Placebo | 48.7 (34.1;63.3) | −4.00 (−38.45;48.70) | ||
Melatonin | 43.3 (29.0; 73.3) | 2.10 (−26.27;46.77) | ||